The Impact of Administration Strategy of Ticagrelor on Its Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris - a Randomized, Single-center, Open-label Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Ticagrelor (Primary)
- Indications Angina pectoris
- Focus Pharmacokinetics
- 18 Oct 2016 Status changed from active, no longer recruiting to completed.
- 21 Aug 2016 Planned number of patients changed from 30 to 49.
- 21 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.